Showing results (561-570 of 4,005) with videos related to

Sort By:
Pageof 401
The FEBS Journal|April 5, 2017
Neutrophil extracellular traps can serve as platforms for processing and activation of IL-1 family cytokinesDanielle M Clancy, Conor M Henry, Graeme P Sullivan, et al.
Cell Reports|June 2, 2015
Diverse Activators of the NLRP3 Inflammasome Promote IL-1β Secretion by Triggering NecrosisSean P Cullen, Conor J Kearney, Danielle M Clancy, et al.
The Journal of Biological Chemistry|June 5, 1991
Protein synthesis inhibitors activate glucose transport without increasing plasma membrane glucose transporters in 3T3-L1 adipocytesB M Clancy, S A Harrison, J M Buxton, et al.
Scientific Reports|July 20, 2017
Increased Male-Male Mounting Behaviour in Desert Locusts during Infection with an Entomopathogenic FungusLisa M Clancy, Amy L Cooper, Gareth W Griffith, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 29, 2001
Synthesis, hydrolysis kinetics and anti-platelet effects of isosorbide mononitrate derivatives of aspirinJ F Gilmer, L M Moriarty, D F McCafferty, et al.
The Journal of Biological Chemistry|November 25, 1990
Insulin regulation of hexose transport in mouse 3T3-L1 cells expressing the human HepG2 glucose transporterS A Harrison, J M Buxton, B M Clancy, et al.
Journal of Chemical Ecology|January 11, 2014
Influence of diterpene resin acids on feeding and growth of larch sawfly,Pristiphora erichsonii (Hartig)M R Wagner, D M Benjamin, K M Clancy, et al.
Environmental Science & Technology|October 4, 2012
Optimization of arsenic removal water treatment system through characterization of terminal electron accepting processesGiridhar Upadhyaya, Tara M Clancy, Jess Brown, et al.
Eating Disorders|June 12, 2026
Tuning in: acceptability and feasibility study of an interoceptive awareness program adapted for eating disordersApril R Smith, Lauren E Pictor, Olivia M Clancy, et al.
British Journal of Pharmacology|March 7, 1998
Characterization of [125I]-PD164333, an ETA selective non-peptide radiolabelled antagonist, in normal and diseased human tissuesA P Davenport, R E Kuc, M J Ashby, et al.
Pageof 401